Abstract:Translational medicine has newly emerged to bridge the gap between bench-related basic science research and bedside clinical practice. From early diagnosis to late-stage disease treatment, translational medicine has transformed the clinical practice by making personalized medicine possible. Attributing to the progress in translational medical research, cancer therapy has evolved from non-specific cytotoxic drugs against both tumor and normal proliferating cells to more specific small molecule chemical and immunotherapy approaches. Small molecular agents are directed at unique pathogenesis of cancer cells, whereas immunotherapeutic agents target the cancer immune response. Both approaches aim to produce less toxicity with high effectiveness. Therapeutic regimens with these agents in biomarker-classified sensitive populations promises a personalized approach in modern oncology. Here we use targeted cancer therapy as an example to elucidate translational medicine in transforming the oncology practice. Targeted cancer therapy using chemicals of low molecular weight, monoclonal antibodies, or polypeptides to interfere with specific signal pathways in cancer cells inhibits cancer progression. Clinical evidence has demonstrated that targeted cancer therapy has a promising potential not only in killing cancers but also by inducing cancer cells to differentiate into normal cells, leading to patient cures. Furthermore, targeted cancer therapy leads to potent inhibition of tumorigenic signals. Delaying rapid cancer progression makes the patients “survive with cancer,” thus making cancer a manageable chronic disease in the future, similar to diabetes and hypertension. This editorial opinion reviewed the theory, features, and future direction of molecular target therapy.

Molecular Target Therapy: a Milestone on the Road for Curing Cancer

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Molecular Targeted Therapy of Cancer: the Progress and Future Prospect

Molecular-targeted Therapy for Cancer

Molecular targeted therapy: Treating cancer with specificity

Molecular targeted therapy for anticancer treatment

Translational medicine promising personalized therapy in oncology

Research Progress in Molecular Targeted Therapy for Gynecological Cancer

Molecular-targeted agents combination therapy for cancer: developments and potentials

Molecularly targeted cancer therapy: some lessons from the past decade

Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges

Research advances of targeted therapy of cancer

Molecular-targeted therapy of pancreatic carcinoma and its progress

Advances on Molecular Targeted Anti-Tumor Drugs

Receptor-Targeted Cancer Therapy

Advances in Molecularly Targeted Cancer Therapy

Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours

Overview of molecular diagnosis and targeted treatment of tumor

Targeting Tumor Suppressor Genes for Cancer Therapy

Small Molecule Inhibitors Targeting the Cancers

Molecular targeted therapy for the treatment of gastric cancer